No more than seven cases ofsulphasalazine-induced lupus have been previously reported. We describe a unique case of systemic lupus erythematosus (SLE) in a woman with a pre-existing 'sicca syndrome'. It is recognized that patients with Sjogren's syndrome (the addition of any systemic connective disease to the 'sicca syndrome' of dry eyes and dry mouth) are more prone to untoward drug reactions (Bloch et al. 1965) .
Case report
Mrs A W, born 11.9.1914, developed the 'sicca syndrome' in 1971. In January 1973 after returning from a Spanish holiday, she began passing up to twelve liquid motions a day with pus and blood. Ulcerative colitis was diagnosed by sigmoidoscopy, barium enema and biopsy. Full autoantibody screening, including rheumatoid factor and antinuclear factor (ANF), was negative. She was given a six-month course of prednisolone, and sulphasalazine Ig three times a day was continued until her 1975 admission. In May 1974she complained of pain, stiffness and swelling of hands, wrists and elbows and tender subcutaneous patches and nodules were noted on her face, limbs and scalp, with surrounding hair loss. ANF was positive in a titre of I in 1280 and skin biopsy showed a nonspecific vasculitis. In January 1975 she developed retrostemal chest pain radiating to jaw and left elbow, worsened by inspiration and movement. Scarred areas over the scalp and the dorsal aspects of fingers were noted. She had pyrexia (38SC), a gallop rhythm and a pleuropericardial rub.
Investigations showed haemoglobin 11.6 g/dl, white cell count 4.3 x 10 9/1 (normal differential); ESR 60 mm in first hour. Normal results were obtained for: urine analysis, blood urea, electrolytes, liver function tests and creatinine phosphokinase. ANF was positive I in 160; LE latex test was positive; anti-DNA antibodies were 'slightly raised', Total haemolytic complement: 28 units/ml (normal 30-46) ; normal C3 and C4 components. Chest X-ray: enlarged cardiac shadow and bilateral basal pleural effusions. Blood, stool and urine cultures were negative.
Sulphasalazine was stopped and intravenous antibiotics and steroids started. She made a speedy recovery and remains well four years later, with persistently negative ANF tests.
Discussion
Alarcon Segovia et al. (1965) described 8 cases of SLE occurring in ulcerative colitics and commented that 5 had been treated with sulphasalazine. In 4 patients the arthralgias, polyserositis and positive LE cells disappeared on withdrawal of the drug. However, this report made no indictment of the drug and merely concluded that ulcerative colitis may be a clue to a 'lupus diathesis ', Both Griffiths & Kane (1977) and Jaup (1978) described further, cases in which repeat challenge with sulphasalazine led to reappearance of the clinical and serological syndrome. We did not consider it justified to rechallenge our patient but feel confident of the causative role of the drug in view of the previously negative ANF, the high' titres during the course of the disease, and its disappearance with clinical recovery after drug withdrawal. 
